BioCryst Pharmaceuticals | BCRX - Ebitda





Ebitda Cambiamento Data
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Chugai Pharma JPY 158.77B 10.24B 2026-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
DBV Technologies USD -45.9M 12.42M 2026-03
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Glaxosmithkline GBP 2.77B 1.98B 2026-03
Incyte USD 367.97M 46.53M 2026-03
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novavax USD 19.36M 190.79M 2025-12
PTC Therapeutics USD -70.99M 91.62M 2025-12
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 13.43B 744M 2026-06
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03